Alcon Expands Glaucoma Portfolio Into Surgical Devices With Optonol Buy
This article was originally published in The Gray Sheet
Executive Summary
Alcon will enter the surgical glaucoma market with its acquisition of Israel-based Optonol, maker of miniature implants to reduce intraocular pressure